TY - JOUR
T1 - Clonal characterization of the human IgG antibody repertoire to Haemophilus influenzae type b polysaccharide
T2 - V. In vivo expression of individual antibody clones is dependent on Ig CH haplotypes and the categories of antigen
AU - Chung, Gook Hyun
AU - Scott, Mitchell G.
AU - Kim, Kyung H.
AU - Kearney, John
AU - Siber, George R.
AU - Ambrosino, Donna M.
AU - Nahm, Moon H.
PY - 1993
Y1 - 1993
N2 - Antibodies (Ab) to the polysaccharide capsule of Haemophilus influenzae type b (Hib-PS) provide protection against Haemophilus influenzae type b disease in children, and Hib-PS vaccines with different immunologie properties are widely used clinically. The repertoire of human anti-Hib-PSAb induced by these vaccines is relatively restricted and can be divided into two types by the structure of the light chain V region. Ab using A2-VΚll gene product, which account for the majority of anti-Hib-PSAb response in most patients, show little somatic mutations. In contrast, non-Ab using A2-VΚII gene product use VL genes from the VΚII, VΚII, VΚIII, VΚIV, and Vλ subgroups, are variably expressed among patients, and contain somatic mutations. To further study the expression of these two types of anti-Hib-PS Ab, we have produced KB13, a mAb specific for VΚII subgroup, and used mAb specific for various other VL subgroups to develop immunoassays specific for anti-Hib-PS Ab of each VL subgroup. When Ig allotypes were studied for the effect on the Ab repertoire, A2-VΚII (A2) Ab were found to be expressed less in patients expressing fb or zag CH haplotypes (p < 0.05). When the T cell-independent Hib-PS carbohydrate vaccine was compared to two T cell-dependent Hib-PS protein conjugate vaccines for their effect on Ab repertoire, Ab using VΚIII VL were found tobe more often elicited with the conjugate vaccines than with the Hib-PS carbohydrate vaccine ( p < 0.01 ). Thus, individual members of the anti-Hib-PS Ab repertoire differ not only in their V region structure but also in the control of their expression.
AB - Antibodies (Ab) to the polysaccharide capsule of Haemophilus influenzae type b (Hib-PS) provide protection against Haemophilus influenzae type b disease in children, and Hib-PS vaccines with different immunologie properties are widely used clinically. The repertoire of human anti-Hib-PSAb induced by these vaccines is relatively restricted and can be divided into two types by the structure of the light chain V region. Ab using A2-VΚll gene product, which account for the majority of anti-Hib-PSAb response in most patients, show little somatic mutations. In contrast, non-Ab using A2-VΚII gene product use VL genes from the VΚII, VΚII, VΚIII, VΚIV, and Vλ subgroups, are variably expressed among patients, and contain somatic mutations. To further study the expression of these two types of anti-Hib-PS Ab, we have produced KB13, a mAb specific for VΚII subgroup, and used mAb specific for various other VL subgroups to develop immunoassays specific for anti-Hib-PS Ab of each VL subgroup. When Ig allotypes were studied for the effect on the Ab repertoire, A2-VΚII (A2) Ab were found to be expressed less in patients expressing fb or zag CH haplotypes (p < 0.05). When the T cell-independent Hib-PS carbohydrate vaccine was compared to two T cell-dependent Hib-PS protein conjugate vaccines for their effect on Ab repertoire, Ab using VΚIII VL were found tobe more often elicited with the conjugate vaccines than with the Hib-PS carbohydrate vaccine ( p < 0.01 ). Thus, individual members of the anti-Hib-PS Ab repertoire differ not only in their V region structure but also in the control of their expression.
UR - http://www.scopus.com/inward/record.url?scp=0027507606&partnerID=8YFLogxK
M3 - Article
C2 - 8409407
AN - SCOPUS:0027507606
SN - 0022-1767
VL - 151
SP - 4352
EP - 4361
JO - Journal of Immunology
JF - Journal of Immunology
IS - 8
ER -